Status
Conditions
Treatments
About
The study is a cluster randomized controlled trial developed in counties located in Appalachia and the Midwest. We will prioritize counties from states with high risk for HIV and HCV infection associated with injection drug use.
Full description
The study will randomize clusters with groups of participants to an intervention or a standard of care condition.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
459 participants in 2 patient groups
Loading...
Central trial contact
Dolores Albarracin, PhD; Christopher J Quasti, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal